A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
Active, not recruiting · NCT06581575 · Registry updated 2026-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine | DNA Virus Infections, Disease Attributes, Herpesviridae infectious disease, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Varicella Zoster Virus Infection, herpes zoster, infectious disease, viral infectious disease | Active, not recruiting | Phase 2 | 2026-04-23 | NCT06581575 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Immorna Biotherapeutics, Inc. | 3 |
| Tigermed Consulting Co., Ltd | 6 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| DelRicht Research | Charleston | United States | 4 |
| DelRicht Research | Prosper | United States | 4 |
| DM Clinical Research - Chicago | Chicago | United States | 1 |
| DM Clinical Research - New Jersey | Jersey City | United States | 2 |
| DM Clinical Research - Sugarland | Sugar Land | United States | 3 |
| Long Beach Research Institute | Long Beach | United States | 11 |
| Noble Clinical Research | Tucson | United States | 14 |
| Quality Clinical Research | Omaha | United States | 6 |